CN Stock MarketDetailed Quotes

Wuhan Keqian Biology Co.,Ltd (688526)

Watchlist
  • 16.15
  • +0.01+0.06%
Market Closed Jan 16 15:00 CST
7.53BMarket Cap16.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Wuhan Keqian Biology Co.,Ltd (688526) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Veterinary biological products461.17M94.64%
Other21.73M4.46%
Other business4.39M0.90%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
兽用生物制品行业895.96M95.12%
Other37.09M3.94%
Other business8.88M0.94%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic482.9M99.10%
Other business4.39M0.90%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.41%
Sample Name
Sample Code
 +2.66%
Sample Name
Sample Code
 +2.26%
4
Broadcom
AVGO
+1.34%
5
Clean Energy Fuels
CLNE
+0.91%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -